25 April 2025 | Friday | News
Picture Courtesy | Public Domain
MDDAP is empowering professionals with new opportunities to excel in the medical device sector through a cutting-edge learning pathway designed for the Voluntary Improvement Program (VIP). This initiative provides essential certifications leveraging the Medical Device Discovery Appraisal Program (MDDAP), equipping appraisers to grow in their careers, access new revenue opportunities, and contribute to continuous improvement efforts within the industry.
MDDAP is a tailored version of the CMMI framework and provides a model and method by which medical device manufactures can better understand, measure, and improve their capability to develop high quality devices. VIP, which is a specialized program developed in tandem with the FDA, the medical device industry, and the Medical Device Innovation Consortium (MDIC), uses MDDAP as a key component to support medical device makers.
The MDDAP certifications entail a mix of coursework, observations, and apprenticeships for those who want to become an MDDAP Appraisal Team Member (ATM) or MDDAP Appraisal Team Lead (ATL). MDDAP launched the ATL certification at the end of March with the development of a new self-paced, eLearning course and Observation process, opening the door for MedTech professionals to join the growing community of MDDAP appraisers.
“Through this new learning pathway, those earning an MDDAP certification not only have the potential to expand their business offerings, reach new clients, and become more skilled in their profession with new training, but also have the opportunity to contribute to the safety and efficacy of medical devices and patient outcomes,” says Kim Kaplan, ISACA Principal Product Manager, MDDAP.
© 2025 Biopharma Boardroom. All Rights Reserved.